Advertisement
Screener

Seelos Therapeutics, Inc. Form D

Seelos Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-07-30: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2024-07-11; Total offering amount $1,146,481.
  • 2024-05-31: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2024-05-21; Total offering amount $2,042,954.
  • 2024-02-14: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2024-01-30; Total offering amount $3,574,468.
  • 2020-09-14: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2020-09-09; Total offering amount $5,584,950.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-07-30Rule 506(b)OptionToAcquire; SecurityToBeAcquired2024-07-11$1,146,481$0$1,146,4813
2024-05-31Rule 506(b)OptionToAcquire; SecurityToBeAcquired2024-05-21$2,042,954$0$2,042,9542
2024-02-14Rule 506(b)OptionToAcquire; SecurityToBeAcquired2024-01-30$3,574,468$0$3,574,4683
2020-09-14Rule 506(b)OptionToAcquire; SecurityToBeAcquired2020-09-09$5,584,950$0$5,584,95013
2019-08-30Rule 506(b)OptionToAcquire; SecurityToBeAcquired2019-08-27$3,982,750$0$3,982,7509
2017-09-27Rule 506(c)Equity; OptionToAcquire2017-09-13$3,691,000$3,691,000$09
2016-10-13Rule 506(c)OptionToAcquire2016-09-28$3,653,106$3,653,106$02
2010-03-18Rule 506Debt; SecurityToBeAcquired2010-03-15$4,000,000$4,000,000$03
2010-03-10Rule 506Debt; SecurityToBeAcquired2010-02-04$2,500,000$2,300,000$200,0003